Table I.
Drug combinations used in Phase 1 trial of lomeguatrib and temozolomide.
| Dosage |
||||||||
|---|---|---|---|---|---|---|---|---|
| Agent | d 1 | d 2 | d 3 | d 4 | d 5 | d 6 | d 7 | d 8 |
| Lomeguatrib (mg/m2/day) | 10 | 10 | 10 | 10 | 10 | 10 | 20 | 40 |
| Temozolomide (mg/m2/day) | 50 | 75 | 100 | 125 | 150 | 175 | 125 | 125 |
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.